Science is improving at re-engineering micro-organisms for all styles of uses, from larger scientific therapies to extra durable materials. However there are peaceful hurdles to beat, including scaling the technique.
Boston-essentially based fully Ginkgo Bioworks become as soon as one of the main billion-buck corporations in the artificial biology house. The NYSE-listed firm uses machine studying and automation to coax biology to work at industrial scale. COO Reshma Shetty talks to Azeem Azhar about the firm’s technology, business model, and the draw mountainous she thinks synthetic biology might perchance well perchance change into.
@Azeem
@exponentialview
@reshmapshetty
Additional resources:
The Bio Revolution: Enhancements remodeling economies, societies, and our lives – McKinsey, Might merely 2020
Engineering Biology: The Next Frontier – Exponential Interrogate Podcast ft. Vijay Pande, June 2020
The Next Trillion-Buck Market – Exponential Interrogate Podcast ft. Deep Nishar, April 2020
A transcript of this episode will seemingly be accessible by March 2, 2022.
